Liu Yu-Chi, Setiawan Melina, Chin Jia Ying, Wu Benjamin, Ong Hon Shing, Lamoureux Ecosse, Mehta Jodhbir S
Tissue Engineering and Cell Therapy Group, Singapore Eye Research Institute, Singapore, Singapore.
Cornea and Refractive Surgery Group, Singapore Eye Research Institute, Singapore, Singapore.
Front Med (Lausanne). 2021 Dec 17;8:811093. doi: 10.3389/fmed.2021.811093. eCollection 2021.
To compare 1-year clinical outcomes, phacoemulsification energy, aqueous profiles, and patient-reported outcomes of low-energy femtosecond laser-assisted cataract surgery (FLACS) vs. conventional phacoemulsification. The study is a randomized controlled trial (RCT) with paired-eye design. Eighty-five patients were randomized to receive FLACS (Ziemer LDV Z8) in one eye and conventional phacoemulsification in the fellow eye. Clinical data including phacoemulsification energy parameters (cumulative dissipated energy, phacoemulsification power, and phacoemulsification time), uncorrected and corrected distance visual acuities (UCDVA and BCDVA), manifest refraction spherical equivalent (MRSE), central corneal thickness (CCT), endothelial cell count (ECC), anterior chamber flare, and post-operative complications were obtained for 1 year. Aqueous humor was collected for the analysis of prostaglandin (PGE), cytokines and chemokines concentrations. Patients' reported-outcomes on surgical experiences were evaluated using an in-house questionnaire. Compared to conventional phacoemulsification, the low-energy assisted FLACS group had significantly less ECC reduction at 3 months (1.5 ± 0.3% vs. 7.0 ± 2.4%; < 0.01) and 1 year (8.2 ± 2.8% vs. 11.2 ± 3.6%; = 0.03). There were no significant differences in the phacoemulsification energy parameters, UCDVA, BCDVA, MRSE, CCT, occurrence of post-operative complications between the 2 groups throughout post-operative 1 year. Patients' subjective surgical experiences, including the surgical duration and perceived inconvenience, were comparable between the 2 groups. FLACS resulted in significantly higher aqueous PGE ( < 0.01), interleukin (IL)-6 ( = 0.03), IL-8 ( = 0.03), and interferon (IFN)-γ ( = 0.04) concentrations and greater anterior chamber flare at 1 day ( = 0.02). Our RCT presented 1-year longitudinal clinical and laboratory data. The long-term ECC result was more favorable in low-energy FLACS. The rest of the intraoperative and post-operative outcomes, as well as patient-reported outcomes, were comparable between these two procedures.
为比较低能量飞秒激光辅助白内障手术(FLACS)与传统超声乳化白内障吸除术的1年临床疗效、超声乳化能量、房水情况及患者报告的结局。本研究是一项采用双眼配对设计的随机对照试验(RCT)。85例患者被随机分配,一只眼接受FLACS(Ziemer LDV Z8),另一只眼接受传统超声乳化白内障吸除术。收集包括超声乳化能量参数(累积消散能量、超声乳化功率和超声乳化时间)、未矫正和矫正远视力(UCDVA和BCDVA)、明显验光球镜等效度(MRSE)、中央角膜厚度(CCT)、内皮细胞计数(ECC)、前房闪光及术后并发症等临床数据,为期1年。采集房水用于分析前列腺素(PGE)、细胞因子和趋化因子浓度。使用一份内部问卷评估患者关于手术体验的报告结局。与传统超声乳化白内障吸除术相比,低能量辅助FLACS组在3个月时ECC降低明显更少(1.5±0.3%对7.0±2.4%;P<0.01),在1年时也是如此(8.2±2.8%对11.2±3.6%;P = 0.03)。在术后1年期间,两组之间的超声乳化能量参数、UCDVA、BCDVA、MRSE、CCT、术后并发症发生率均无显著差异。两组患者的主观手术体验,包括手术时长和感知到的不便程度,具有可比性。FLACS导致术后1天时房水PGE(P<0.01)、白细胞介素(IL)-6(P = 0.03)、IL-8(P = 0.03)和干扰素(IFN)-γ(P = 0.04)浓度显著更高,前房闪光更明显(P = 0.02)。我们的RCT展示了1年的纵向临床和实验室数据。低能量FLACS的长期ECC结果更优。这两种手术的其余术中及术后结局,以及患者报告的结局,具有可比性。